Tyme To Present Prostate Cancer Data From Its Ongoing Phase II Trial For SM-88 At Post author:Sam Post published:August 28, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like MacroGenics Announces Registered Direct Offering Of Common Stock April 26, 2017 Taro Provides Results For December 31, 2016 February 9, 2017 J&J Wins FDA Nod for Erleada, the First Drug for Nonmetastatic Prostate Cancer February 14, 2018